Full Year Results FY26 August 2026 Advanced Manufacturing for Breakthrough Medicines Disclaimer and Important Notices This presentation has been prepared by IDT Australia Limited ACN 006 522 970 (Company). It contains general background information only which is current at the date of this...
FY26 Full Year Results Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from IDT Australia
- FY26 Appendix 4G and Corporate Governance Statement
- Change of Director's Interest Notice - JR
- Change of Director's Interest Notice - MS
- Change of Director's Interest Notice - GS
- Upgrade to FY26 Guidance
Later from IDT Australia
- FY26 Appendix 4E and Annual Report
- Change in substantial holding
- Notice of Annual General Meeting and Proxy Form
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia